Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1

Cell Death and Differentiation

Volumn 20, Issue 10, 2013, Pages 1425-1434

  Frauenstein, K ^a   Sydlik, U ^a   Tigges, J ^a   Majora, M ^a   Wiek, C ^b   Hanenberg, H ^b   Abel, J ^a   Esser, C ^a   Fritsche, E ^a   Krutmann, J ^a   Haarmann Stemmann, T ^a  

^a IUF LEIBNIZ RESEARCH INSTITUTE FOR ENVIRONMENTAL MEDICINE   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

apoptosis; aryl hydrocarbon receptor; chemoprevention; skin cancer; UVB radiation

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CASPASE 3; CHECKPOINT KINASE 1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1B; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR E2F1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOREGULATION; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DAMAGE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; HAIRLESS MOUSE; HUMAN; HUMAN CELL; IN VIVO STUDY; KERATINOCYTE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHOTOCARCINOGENESIS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIOSENSITIZATION; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; HUMANS; KERATINOCYTES; MALE; MICE; MICE, KNOCKOUT; PROTEIN KINASES; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84883801695     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.102     Document Type: Article

References (61)

1. Bowden GT. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat Rev Cancer 2004; 4: 23-35. (Pubitemid 38082151)
2. Madan V, Lear JT, Szeimies RM. Non-melanoma skin cancer. Lancet 2010; 375: 673-685.
3. Herrlich P, Karin M, Weiss C. Supreme EnLIGHTenment: damage recognition and signaling in the mammalian UV response. Mol Cell 2008; 29: 279-290. (Pubitemid 351215936)
4. Lippens S, Hoste E, Vandenabeele P, Agostinis P, Declercq W. Cell death in skin. Apoptosis 2009; 14: 549-569.
5. Schwarz A, Stander S, Berneburg M, Bohm M, Kulms D, van Steeg H et al. Interleukin-12 suppresses ultraviolet radiation-induced apoptosis by inducing DNA repair. Nat Cell Biol 2002; 4: 26-31. (Pubitemid 34071977)
6. Sun SY, Hail N Jr, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004; 96: 662-672. (Pubitemid 38660229)
7. Kulms D, Poppelmann B, Yarosh D, Luger TA, Krutmann J, Schwarz T. Nuclear and cell membrane effects contribute independently to the induction of apoptosis in human cells exposed to UVB radiation. Proc Natl Acad Sci USA 1999; 96: 7974-7979. (Pubitemid 29328392)
8. Kulms D, Zeise E, Poppelmann B, Schwarz T. DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene 2002; 21: 5844-5851. (Pubitemid 35007234)
9. Yamaguchi Y, Takahashi K, Zmudzka BZ, Kornhauser A, Miller SA, Tadokoro T et al. Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. FASEB J 2006; 20: 1486-1488.
10. Fritsche E, Schafer C, Calles C, Bernsmann T, Bernshausen T, Wurm M et al. Lightening up the UV response by identification of the arylhydrocarbon receptor as a cytoplasmatic target for ultraviolet B radiation. Proc Natl Acad Sci USA 2007; 104: 8851-8856. (Pubitemid 47175400)
11. Abel J, Haarmann-Stemmann T. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol Chem 2010; 391: 1235-1248.
12. Wincent E, Bengtsson J, Mohammadi BA, Alsberg T, Luecke S, Rannug U et al. Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 2012; 109: 4479-4484.
13. Haarmann-Stemmann T, Bothe H, Abel J. Growth factors, cytokines and their receptors as downstream targets of arylhydrocarbon receptor (AhR) signaling pathways. Biochem Pharmacol 2009; 77: 508-520.
14. Agostinis P, Garmyn M, Van Laethem A. The Aryl hydrocarbon receptor: an illuminating effector of the UVB response. Sci STKE 2007; 2007: e49.
15. Dietrich C. The AHR in the Control of Cell Cycle and Apoptosis. In Pohjanvirta R (ed). The AH Receptor in Biology and Toxicology. 1 edn. John Wiley & Sons, Inc.: Hoboken, New Jersey, 2012, pp 467-483.
16. Bakken P, Evans V, Earle W, Stevenson R. Establishment of a strain of human skin cells on chemically defined medium NCTC 109. Am J Hyg 1961; 73: 96-104.
17. Autier P, Dore JF, Reis AC, Grivegnee A, Ollivaud L, Truchetet F et al. Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters. Br J Cancer 2000; 83: 1243-1248.
18. Sutter T, Guzman K, Dold K, Greenlee W. Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1 beta. Science 1991; 254: 415-418. (Pubitemid 21917355)
19. Neuman E, Flemington EK, Sellers WR, Kaelin WG Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA-binding sites within its promoter. Mol Cell Biol 1994; 14: 6607-6615. (Pubitemid 24299729)
20. Johnson DG, Ohtani K, Nevins JR. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev 1994; 8: 1514-1525. (Pubitemid 24218286)
21. Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME et al. Bcl-2 retards cell cycle entry through p27Kip1, pRB relative p130, and altered E2F regulation. Mol Cell Biol 20 4745-4753.
22. Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N et al. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 1997; 243: 527-536. (Pubitemid 27060443)
23. Carrassa L, Broggini M, Vikhanskaya F, Damia G. Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites. Cell Cycle 2003; 2: 604-609.
24. Verlinden L, Vanden BI, Eelen G, Drijkoningen M, Verlinden I, Marchal K et al. The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor/progesterone receptor /HER-2 breast carcinomas. Cancer Res 2007; 67: 6574-6581. (Pubitemid 47105501)
25. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J et al. Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci USA 2000; 97: 779-782. (Pubitemid 30070386)
26. Andersson P, McGuire J, Rubio C, Gradin K, Whitelaw ML, Pettersson S et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc Natl Acad Sci USA 2002; 99: 9990-9995. (Pubitemid 34831160)
27. Mulero-Navarro S, Pozo-Guisado E, Perez-Mancera PA, Alvarez-Barrientos A, Catalina-Fernandez I, Hernandez-Nieto E et al. Immortalized mouse mammary fibroblasts lacking dioxin receptor have impaired tumorigenicity in a subcutaneous mouse xenograft model. J Biol Chem 2005; 280: 28731-28741. (Pubitemid 41105774)
28. Puppala D, Gairola CG, Swanson HI. Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation. Carcinogenesis 2007; 28: 639-647. (Pubitemid 46523359)
29. Palermo CM, Hernando JI, Dertinger SD, Kende AS, Gasiewicz TA. Identification of potential aryl hydrocarbon receptor antagonists in green tea. Chem Res Toxicol 2003; 16: 865-872. (Pubitemid 36899001)
30. Ciolino HP, Daschner PJ, Yeh GC. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 1998; 58: 5707-5712. (Pubitemid 29006410)
31. Aziz MH, Reagan-Shaw S, Wu J, Longley BJ, Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 2005; 19: 1193-1195. (Pubitemid 40946462)
32. Bell LA, Ryan KM. Life and death decisions by E2F-1. Cell Death Differ 2004; 11: 137-142. (Pubitemid 38159637)
33. Polager S, Ginsberg D. p53 and E2f: partners in life and death. Nat Rev Cancer 2009; 9: 738-748.
34. Urist M, Tanaka T, Poyurovsky MV, Prives C. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev 2004; 18: 3041-3054. (Pubitemid 39658173)
35. Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, Xia Y et al. The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell 2008; 19: 3263-3271.
36. Ghosh R, Nadiminty N, Fitzpatrick JE, Alworth WL, Slaga TJ, Kumar AP. Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity. J Biol Chem 2005; 280: 5812-5819. (Pubitemid 40280062)
37. Spyridopoulos I, Principe N, Krasinski KL, Xu Sh, Kearney M, Magner M et al. Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factoralpha-induced apoptosis. Circulation 1998; 98: 2883-2890. (Pubitemid 29003971)
38. Wikonkal NM, Remenyik E, Knezevic D, Zhang W, Liu M, Zhao H et al. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat Cell Biol 2003; 5: 655-660. (Pubitemid 36818088)
39. Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res 2010; 70: 212-220.
40. Kolluri SK, Weiss C, Koff A, Gottlicher M. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev 1999; 13: 1742-1753. (Pubitemid 29325878)
41. Kalmes M, Hennen J, Clemens J, Blomeke B. Impact of aryl hydrocarbon receptor (AhR) knockdown on cell cycle progression in human HaCaT keratinocytes. Biol Chem 2011; 392: 643-651.
42. Dever DP, Opanashuk LA. The aryl hydrocarbon receptor contributes to the proliferation of human medulloblastoma cells. Mol Pharmacol 2012; 81: 669-678.
43. Gomez-Duran A, Ballestar E, Carvajal-Gonzalez JM, Marlowe JL, Puga A, Esteller M et al. Recruitment of CREB1 and histone deacetylase 2 (HDAC2) to the mouse Ltbp-1 promoter regulates its constitutive expression in a dioxin receptor-dependent manner. J Mol Biol 2008; 380: 1-16.
44. Yang X, Liu D, Murray TJ, Mitchell GC, Hesterman EV, Karchner SI et al. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene 2005; 24: 7869-7881. (Pubitemid 41715193)
45. Murata K, Hattori M, Hirai N, Shinozuka Y, Hirata H, Kageyama R et al. Hes1 directly controls cell proliferation through the transcriptional repression of p27Kip1. Mol Cell Biol 2005; 25: 4262-4271. (Pubitemid 40617671)
46. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z et al. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 2001; 20: 1688-1702. (Pubitemid 32368016)
47. Wang X, Gorospe M, Huang Y, Holbrook NJ. p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 1997; 15: 2991-2997. (Pubitemid 28008992)
48. Gupta S, Hussain T, Mukhtar H. Molecular pathway for (-)- epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys 2003; 410: 177-185. (Pubitemid 36268810)
49. Nihal M, Ahmad N, Mukhtar H, Wood GS. Anti-proliferative and proapoptotic effects of (-)-epigallocatechin-3-gallate on human melanoma: possible implications for the chemoprevention of melanoma. Int J Cancer 2005; 114: 513-521. (Pubitemid 40349609)
50. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000; 408: 433-439.
51. Ma CX, Janetka JW, Piwnica-Worms H. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med 2011; 17: 88-96.
52. Heffernan TP, Kawasumi M, Blasina A, Anderes K, Conney AH, Nghiem P. ATR-Chk1 pathway inhibition promotes apoptosis after UV treatment in primary human keratinocytes: potential basis for the UV protective effects of caffeine. J Invest Dermatol 2009; 129: 1805-1815.
53. Lu YP, Lou YR, Peng QY, Xie JG, Nghiem P, Conney AH. Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice. Cancer Res 2008; 68: 2523-2529. (Pubitemid 351521829)
54. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS et al. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc Natl Acad Sci USA 2002; 99: 12455-12460.
55. Abel EL, Hendrix SO, McNeeley SG, Johnson KC, Rosenberg CA, Mossavar-Rahmani Y et al. Daily coffee consumption and prevalence of nonmelanoma skin cancer in Caucasian women. Eur J Cancer Prev 2007; 16: 446-452. (Pubitemid 47550005)
56. Jacobsen BK, Bjelke E, Kvale G, Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 1986; 76: 823-831. (Pubitemid 16121938)
57. Jux B, Kadow S, Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol 2009; 182: 6709-6717.
58. Jux B, Kadow S, Luecke S, Rannug A, Krutmann J, Esser C. The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning. J Invest Dermatol 2011; 131: 203-210.
59. Matikainen T, Perez GI, Jurisicova A, Pru JK, Schlezinger JJ, Ryu HY et al. Aromatic hydrocarbon receptor-driven Bax gene expression is required for premature ovarian failure caused by biohazardous environmental chemicals. Nat Genet 2001; 28: 355-360. (Pubitemid 32702425)
60. Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1: 1458-1461.
61. Schmidt JV, Su GH, Reddy JK, Simon MC, Bradfield CA. Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci USA 1996; 93: 6731-6736. (Pubitemid 26230378)